PEAK6 Investments’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
PEAK6 Investments's RGEN Position: Q2 2023 in Review
PEAK6 Investments sold out of Repligen (RGEN) in Q2 2023, closing a stake of 291 shares — an estimated $49K sold.
PEAK6 Investments first reported a position in RGEN in Q1 2020 and held it in 9 quarters. The position peaked at $1.22M in Q1 2021. 448 funds tracked by Wall St. Rank hold RGEN as of Q2 2023.
- PEAK6 Investments reported no remaining Repligen position as of Q2 2023 after selling out during the quarter.
- PEAK6 Investments sold 291 Repligen shares in Q2 2023, an estimated $49K.
- PEAK6 Investments first reported a position in Repligen in Q1 2020 and held it in 9 quarters.
- PEAK6 Investments's Repligen position peaked at $1.22M in Q1 2021.
- 448 funds tracked by Wall St. Rank held Repligen as of Q2 2023.
Based on PEAK6 Investments's 13F filing for Q2 2023, filed 11 Aug 2023.